Page last updated: 2024-09-03

3,3a-dehydropyrazidol and methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate

3,3a-dehydropyrazidol has been researched along with methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate in 1 studies

Compound Research Comparison

Studies
(3,3a-dehydropyrazidol)
Trials
(3,3a-dehydropyrazidol)
Recent Studies (post-2010)
(3,3a-dehydropyrazidol)
Studies
(methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate)
Trials
(methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate)
Recent Studies (post-2010) (methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate)
901218018

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chulkova, TM; Fedotova, OA; Medvedev, AE; Saederup, E; Shvedov, VI; Squires, RF1

Other Studies

1 other study(ies) available for 3,3a-dehydropyrazidol and methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate

ArticleYear
The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding.
    Journal of neural transmission. Supplementum, 1998, Volume: 52

    Topics: Animals; Antidepressive Agents; Benzodiazepinones; Brain; Carbazoles; Carbolines; Clozapine; Female; GABA Antagonists; Humans; Isoenzymes; Kinetics; Mitochondria; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Placenta; Pregnancy; Rats; Receptors, GABA-A

1998